aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
0.528
-0.032 (-5.75%)
At close: Jun 26, 2026, 4:00 PM EDT
0.550
+0.023 (4.28%)
After-hours: Jun 26, 2026, 7:27 PM EDT
aTyr Pharma Stock Forecast
ATYR's stock price has decreased by -89.68% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts with 12-month price forecasts for aTyr Pharma stock have an average target of 6.38, with a low estimate of 1.00 and a high estimate of 20. The average target predicts an increase of 1,109.48% from the current stock price of 0.53.
Analyst Consensus: Buy
* Price targets were last updated on May 20, 2026.
Analyst Ratings
The average analyst rating for aTyr Pharma stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 8 | 7 | 7 | 6 | 6 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 10 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Freedom Capital Markets | Freedom Capital Markets | Buy Upgrades $1 → $3.5 | Buy | Upgrades | $1 → $3.5 | +563.51% | May 20, 2026 |
| Wells Fargo | Wells Fargo | Hold Reiterates $1 | Hold | Reiterates | $1 | +89.57% | May 18, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $1 | Hold | Maintains | $1 | +89.57% | May 15, 2026 |
| JonesTrading | JonesTrading | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 15, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 | Buy | Maintains | $20 | +3,691.47% | May 12, 2026 |
Financial Forecast
Revenue This Year
n/a
from 190.00K
Decreased by -100.00%
Revenue Next Year
n/a
EPS This Year
-0.54
from -0.80
EPS Next Year
-0.64
from -0.54
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -100.0% | - | |
| Avg | -100.0% | - | |
| Low | -100.0% | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.54 | -0.64 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.